Podcast Episodes
Back to Search
Gemma Explored: Pioneering Open AI with Google
In this episode, we delve into the specifics of Gemma, Google's pioneering open nature AI model, exploring its contributions to the AI field and how …
2 years, 6 months ago
Surging AI Ventures: Anthropic's Scale and Abridge's Growth
In this episode, we delve into the recent surge in AI venture deals, focusing on the scale expansion of Anthropic and the perplexing growth of Abridg…
2 years, 6 months ago
Microsoft's AI Server Gear: A Bold Move Beyond Nvidia
In this episode, we delve into Microsoft's strategic development of proprietary AI server hardware, aiming to reduce its reliance on Nvidia. We explo…
2 years, 6 months ago
AI's Influence in Business Analytics: A Conversation with Chata.ai's CEO Kelly Cherniwchan
In this episode, I explore the evolving landscape of AI in business analytics, elucidated by Chata.ai's CEO Kelly Cherniwchan, shedding light on the …
2 years, 7 months ago
Navigating Restrictions: U.S. Imposes Limits on Nvidia, AMD AI Chip Exports to Middle East
In this episode, I navigate through the implications of the U.S. restrictions on Nvidia and AMD, restricting AI chip exports to the Middle East, anal…
2 years, 7 months ago
AI Unveiled: Baidu's Progress, IBM's Affection for Salesforce, .ai's Capital Infusion, and X's Policy Reform
This episode unveils the latest in AI news, including Baidu's strides, IBM's alignment with Salesforce, .ai's funding news, and the policy reform upd…
2 years, 7 months ago
Paula Phelan on AI's Evolution in PR: Insights from Intelligent Relations' COO
In this episode, we examine the evolving role of AI in public relations, as discussed by Paula Phelan, the COO of Intelligent Relations, outlining th…
2 years, 7 months ago
AI vs. Toxicity: Call of Duty and Modulate's Initiative for a Better Gaming Atmosphere
In this episode, we analyze the efforts of Call of Duty and Modulate, leveraging AI to combat toxicity in voice chats, aiming to create a more positi…
2 years, 7 months ago
QuantHealth's Funding Triumph: Boosting AI-Driven Clinical Drug Trials in the US
In this episode, we dissect the significance of QuantHealth's $15 million funding triumph, highlighting its role in advancing AI-centric methodologie…
2 years, 7 months ago
Unraveling OpenAI's GDPR Dilemma: A 4% Global Revenue Penalty Looms
In this episode, we dissect OpenAI's GDPR-related challenges, analyzing the potential consequences and the looming threat of a 4% penalty on their wo…
2 years, 7 months ago